News

Published on 25 Oct 2021 on Entrpreneur

3 Bargain Stocks to Buy and Hold Long Term


Article preview image

The economy is in recovery mode with the rapid roll-out of vaccines. A solid start to the third-quarter earnings season, a decline in the initial jobless...

NASDAQ.BIIB price evolution
NASDAQ.ERIC price evolution
NASDAQ.ACOR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves

gained 5.5% premarket on Wednesday after the company reported first-quarter profit that beat...

Market Watch 24 Apr 2024

Should You Be Confident in Biogen (BIIB)?

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equ...

Insider Monkey via Yahoo Finance 23 Apr 2024

Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on lower revenues when Biogen Inc. (BII...

Zacks via Yahoo Finance 17 Apr 2024

Medicare spending on Biogen’s Alzheimer's drug to hit $3.5B

The U.S. government projects that the newly approved Alzheimer's therapy from Biogen (BIIB)/ Eisa...

Seeking Alpha 16 Apr 2024

US biopharma first quarter earnings seen stable amid low expectations

Expectations for US biopharma companies' first quarter earnings are low given the typical...

Proactive Investors 12 Apr 2024

GLP-1s benefit Parkinson’s: Barclays sees biopharma impact

Barclays cites implications for the biopharma sector after a mid-stage trial showed that the GLP-...

Seeking Alpha 12 Apr 2024

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study

ALX Oncology Holdings Inc. ALXO reported positive results from an ongoing phase I/II investigator...

Zacks via Yahoo Finance 11 Apr 2024

12 Best Depressed Stocks To Buy in 2024

In this article, we will take a detailed look at the 12 Best Depressed Stocks To Buy in 2024. For...

Insider Monkey via Yahoo Finance 10 Apr 2024

Thermo Fisher CEO's compensation dropped by 33% last year - Boston Business Journal

In 2022, Casper's pay package was the fourth-highest in Massachusetts for a CEO of a public compa...

The Business Journals 9 Apr 2024

Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst

Phantom Pharmaceuticals, Rhythm Pharmaceuticals, and Vaxcyte are top takeover candidates in the...

Seeking Alpha 7 Apr 2024